Abiopharma

(85% Positive) Cassava Sciences, Inc. (SAVA) Provides Update on time for Cassava

New Form SCHEDULE 13G - HYPERION DEFI, INC. Filed: 2025-10-22 AccNo: 0001104659-25-101414 Size: 7 KB

New Form 6-K - ASTRAZENECA PLC Filed: 2025-10-22 AccNo: 0001654954-25-012040 Size: 54 KB

New Form SC TO-T/A - Tourmaline Bio, Inc. Filed: 2025-10-22 AccNo: 0001104659-25-101411 Size: 46 KB

LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program

AVDL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avadel Pharmaceuticals plc Is Fair to Shareholders

Equillium - Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

Calidi Biotherapeutics - Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine

Evolus - Evolus to Report Third Quarter Financial Results on November 5, 2025

New Form ARS - GALECTIN THERAPEUTICS INC Filed: 2025-10-22 AccNo: 0001140361-25-038877 Size: 1 MB

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

(99% Neutral) KRYSTAL BIOTECH, INC. (KRYS) Provides Business Update

New Form DEF 14A - GALECTIN THERAPEUTICS INC Filed: 2025-10-22 AccNo: 0001140361-25-038875 Size: 5 MB